Receptor for advanced glycation end products is a promising target of diabetic nephropathy

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 562-566

  Yamamoto, Yasuhiko ^a   Doi, Toshio ^b   Kato, Ichiro ^c   Shinohara, Harumichi ^d   Sakurai, Shigeru ^a   Yonekura, Hideto ^a   Watanabe, Takuo ^a   Myint, Kihn Mar ^a   Harashima, Ai ^a   Takeuchi, Masayoshi ^e   Takasawa, Shin ^c   Okamoto, Hiroshi ^c   Hashimoto, Noriyoshi ^f   Asano, Masahide ^f   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

^e HOKURIKU UNIVERSITY   (Japan)

^f KANAZAWA UNIVERSITY   (Japan)

Author keywords

AGE; Diabetic nephropathy; esRAGE; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; POLYADENYLATED RNA;

CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DISABILITY; DISEASE EXACERBATION; GENE OVEREXPRESSION; HOMOLOGOUS RECOMBINATION; LIFE EXPECTANCY; MOUSE; NONHUMAN; QUALITY OF LIFE; TRANSGENIC MOUSE; WILD TYPE;

MUS MUSCULUS;

EID: 23744458810     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1333.064     Document Type: Conference Paper

References (4)

1. NEEPER, M., A.M SCHMIDT, J. BRETT, et al. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
2. SCHMIDT, A.M., S.D. YAN, S.F. YAN, et al. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108: 949-955.
3. YAMAMOTO, Y., I. KATO, T. DOI, et al. 2001. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108: 261-268.
4. YONEKURA, H., Y. YAMAMOTO, S. SAKURAI, et al. 2003. Novel splice variants of the receptor for advanced glycation endproducts (RAGE) expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370: 1097-1109.